Guillaume Serzian

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Cardiovascular Outcomes After Cardiac Resynchronization Therapy in Cardiac Amyloidosis

Kilian Fischer, Nicolas Lellouche, Thibaud Damy et al. · ESC Heart Failure · 2021 · 19 citations · Full text

Medicine, Cardiology, Clinical Cardiology +7

Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events

Romain Chopard, Guillaume Serzian, S. Humbert et al. · Journal of Thrombosis and Thrombolysis · 2018 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +12

Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation

Romain Chopard, David Jiménez, Guillaume Serzian et al. · Critical Care · 2021 · 16 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Value of HAVOC and Brown ESUS-AF scores for atrial fibrillation on implantable cardiac monitors after embolic stroke of undetermined source

Claire Grygorowicz, Karim Bénali, Guillaume Serzian et al. · Journal of Stroke and Cerebrovascular Diseases · 2023 · 10 citations

Medicine, Cardiology, Electrophysiology +12